5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 5: Patient safety and quality assurance

5PSQ-042 Toxicity of remdesivir as treatment of non-critically ill COVID-19 patients

Free

Online download statistics by month:

Online download statistics by month: March 2022 to September 2024

	Abstract	Full	Pdf
Mar 2022	16	0	1
Apr 2022	38	0	2
May 2022	15	0	2
Jun 2022	37	0	8
Jul 2022	30	0	3
Aug 2022	36	0	4
Sep 2022	25	0	6
Oct 2022	30	0	4
Nov 2022	20	0	1
Dec 2022	26	0	2
Jan 2023	41	0	1
Feb 2023	24	0	3
Mar 2023	34	0	1
Apr 2023	28	0	0
May 2023	46	0	0
Jun 2023	10	0	0
Jul 2023	20	0	5
Aug 2023	18	0	0
Sep 2023	10	0	0
Oct 2023	18	0	1
Nov 2023	22	0	2
Dec 2023	10	0	2
Jan 2024	12	0	3
Feb 2024	10	0	3
Mar 2024	8	0	1
Apr 2024	8	0	0
May 2024	9	0	0
Jun 2024	16	0	3
Jul 2024	2	0	2
Aug 2024	13	0	3
Sep 2024	20	0	1
Total	652	0	64